Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
EV/Core EBITDA

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
   EV/Core EBITDA(x) 24.3118.2430.428.269.00

What is the latest EV/Core EBITDA ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest EV/Core EBITDA ratio of SYNCOM FORMULATIONS (INDIA) is 24.31 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202424.31
Mar202318.24
Mar202230.42
Mar20178.26
Mar20169.00

How is EV/Core EBITDA of SYNCOM FORMULATIONS (INDIA) Trending?

Years EV/Core EBITDA % Change
Mar2024 24.31
33.28
Mar2023 18.24
-40.04
Mar2022 30.42
268.28
Mar2017 8.26
-8.22
Mar2016 9 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare EV/Core EBITDA ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,755.9 Cr -13.1% -6.7% 53.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹395,254.0 Cr -2.5% -4.9% 8.7% Stock Analytics
DIVIS LABORATORIES ₹172,374.0 Cr -2.7% -0.9% 42.5% Stock Analytics
CIPLA ₹119,795.0 Cr -1.5% 0.1% -4.3% Stock Analytics
DR REDDYS LABORATORIES ₹110,698.0 Cr -2.6% 8.3% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,218.0 Cr -2.6% -3.7% 11.9% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-13.1%

-6.7%

53.7%

SENSEX

-0.4%

0.2%

5.9%


You may also like the below Video Courses